Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Design Therapeutics Inc shares valued at $3,463,214 were sold by William Arsani on Aug 09 ’24. At $4.25 per share, William Arsani sold 814,874 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Logos SPV 1 LP purchased 814,874 shares, netting a total of over 3,455,066 in proceeds.
Before that, Schmid John P. had added 17,809 shares to its account. In a trade valued at $66,606, the Director bought Design Therapeutics Inc shares for $3.74 each. Upon closing the transaction, the insider’s holdings increased to 17,809 shares, worth approximately $0.16 million.
As published in a research note from Piper Sandler on May 07, 2024, Design Therapeutics Inc [DSGN] has been rated up from a Neutral to an Overweight and the price target has been revised to $12 from $6. Analysts at Piper Sandler downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in mid November. As of August 15, 2023, Wedbush has decreased its “an Outperform” rating to a “Neutral” for DSGN. Earlier on August 15, 2023, SVB Securities downgraded its rating. Their new recommendation was “a Market perform” for DSGN stock which previously was a “an Outperform”.
Analyzing DSGN Stock Performance
During the last five days, there has been a surge of approximately 8.94%. Over the course of the year, Design Therapeutics Inc shares have jumped approximately 125.28%. Shares of the company reached a 52-week high of $7.77 on 11/13/24 and a 52-week low of $2.24 on 02/13/24. A 50-day SMA is recorded $5.54, while a 200-day SMA reached $4.35. Nevertheless, trading volume fell to 77621.0 shares from 77400.0 shares the previous day.
Support And Resistance Levels for Design Therapeutics Inc (DSGN)
According to the 24-hour chart, there is a support level at 5.81, which, if violated, would cause prices to drop to 5.65. In the upper region, resistance lies at 6.19. The next price resistance is at 6.41. RSI (Relative Strength Index) is 53.16 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.11, which suggests the price will decrease in the coming days. Percent R is at 73.32%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
